Cossio-Gil Yolima

Cossio-Gil Yolima

Vall d’Hebron University Hospital. Catalan Institute of Health. Passeig Vall d’Hebron, Barcelona



Biography

Dr Yolima Cossio-Gil is a Clinical Medical Doctor specialist in Preventive Medicine and Public Health and Masters in Public Health. Research background in epidemiology, vaccines, quality and patient safety. Experience working in health management and policies both in hospitals and primary care, clinical research and epidemiology in Colombia, UK, Spain, South Africa and Southeast-Asia. Currently subdirector of the Data and Innovation Department of the Vall d’Hebron University hospital (Catalan Institue of Health), in Barcelona Spain.

 

Abstract

The aging of the population, the raising in the chronic conditions, the active role of the patients, the changes to regulations and reimbursement, and the explosion of new therapies, information and technology are some of the challenges that health care providers are facing.

To succeed in this era characterized by uncertainty and rapid change, the primary care must become more nimble and proactive. The patients, professionals,  organizations and the governments have to adapt in order to keep the system affordable as well as sustainable and, at the same time, keep up with the latest advances and achieve the best quality.

The information technology applications appear to be the solution that can radically revolutionize and improve the way we do things. However, as there are some great opportunities for improving health with new technologies, there are also concerns for these rapidly evolving technological advancements.

In this conference, I 'll use the five diseases with more burden and economic costs in the world ( CVD, diabetes, COPD, obesity,  cancer, and mental diseases) and I'll describe five case experiences of the application of new technologies: Big data and Artificial Intelligence;  Internet of Medical Things (IoMT); Hybrid Closed-Loop Insulin Delivery System and the Non;  Algorithms to better-purchasing behavior and apps to help patients manage health risk behaviors; genomics and personalized medicine; and virtual reality.

The discussion will be focused on the real evidence of these new technologies, and we’ll go through the reason why some of these strategies had failed and discuss the role of professionals, consumers and the organizations.

There is a need for commitment to a human-centered design, enabling collaboration between all stakeholders through effective and secure communication and guaranteeing the patient engagement as a key component of the solutions.

Finally to remark that technology is not an end but a means. Therefore, it has to enable coordination,  continuous care, reduce cost, and (most importantly): to improve health outcomes and experience of the population.